RPE expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.61710661422876E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.40132391538373E-12 |
Normal-vs-Stage2 |
2.57519999768974E-08 |
Normal-vs-Stage3 |
9.65099999916674E-10 |
Normal-vs-Stage4 |
1.48980050518333E-10 |
Stage1-vs-Stage2 |
5.122600E-01 |
Stage1-vs-Stage3 |
1.387010E-01 |
Stage1-vs-Stage4 |
8.810100E-02 |
Stage2-vs-Stage3 |
4.911800E-01 |
Stage2-vs-Stage4 |
5.075600E-01 |
Stage3-vs-Stage4 |
9.462200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.75846012698366E-12 |
Normal-vs-AfricanAmerican |
6.76180222924927E-11 |
Normal-vs-Asian |
2.498200E-02 |
Caucasian-vs-AfricanAmerican |
1.772960E-01 |
Caucasian-vs-Asian |
6.507800E-01 |
AfricanAmerican-vs-Asian |
2.693600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.22915044598449E-14 |
Normal-vs-Female |
7.59759999358067E-09 |
Male-vs-Female |
5.769800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.68299999492305E-08 |
Normal-vs-Age(41-60Yrs) |
2.69819722120701E-11 |
Normal-vs-Age(61-80Yrs) |
1.72619696314769E-11 |
Normal-vs-Age(81-100Yrs) |
1.02350000030782E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.843640E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.446010E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.431200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.805400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.864050E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.781600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.217900E-03 |
Normal-vs-Grade 2 |
1.11529996349446E-09 |
Normal-vs-Grade 3 |
1.62969637784727E-12 |
Normal-vs-Grade 4 |
1.63870028657698E-10 |
Grade 1-vs-Grade 2 |
4.778600E-01 |
Grade 1-vs-Grade 3 |
2.026800E-01 |
Grade 1-vs-Grade 4 |
1.730980E-01 |
Grade 2-vs-Grade 3 |
1.239030E-01 |
Grade 2-vs-Grade 4 |
1.017580E-01 |
Grade 3-vs-Grade 4 |
4.575200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.87780038582741E-10 |
Normal-vs-ccB subtype |
7.18149983924832E-10 |
ccA subtype-vs-ccB subtype |
2.756400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.74209560508143E-11 |
Normal-vs-N1 |
5.60829999999291E-05 |
N0-vs-N1 |
5.672400E-01 |
|
|